← Back to Patent Explorer
US4466957A Expired / Lapsed US ⏱️ 0.0 years remaining

Vaccine adjuvants

Assignee: Wyeth LLC
•
Filing: 1982-02-25
•
Granted: 1984-08-21
•
Expires: 2002-02-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are disclosed mammalian vaccine compositions comprising an inactivated whole or subunit vaccine or toxoid and an adjuvant having the formula ##STR1## wherein R is hydrogen or lower alkyl, R 1 is hydrogen, lower alkyl, lower alkoxy, trifluoromethyl or halo, R 2 is hydrogen, chloro or nitro, n is 1 or 2 and pharmaceutically acceptable salts thereof.

Inventors

  • 👤 Richard N. Hjorth
  • 👤 Bobby O. Moore
  • 👤 Norman H. Grant

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 23:56
CPC Classifications
C; C07; C07D; C07D513/00; C07D513/02; C07D513/04; A; A61; A61K; A61K39/00; A61K39/39

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 73 words
A mammalian vaccine composition comprising an inactivated whole or subunit virus vaccine and an effective amount of an adjuvant having the formula ##STR3## wherein R is hydrogen or 1 to 6 carbon atom lower alkyl, R 1 is hydrogen, 1 to 6 carbon atom lower alkyl, 1 to 6 carbon atom lower alkoxy, trifluoromethyl or halo, R 2 is hydrogen, chloro or nitro, n is 1 or 2 and pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 73 words
A mammalian vaccine composition comprising an inactivated whole or subunit virus vaccine and an effective amount of an adjuvant having the formula ##STR3## wherein R is hydrogen or 1 to 6 carbon atom lower alkyl, R 1 is hydrogen, 1 to 6 carbon atom lower alkyl, 1 to 6 carbon atom lower alkoxy, trifluoromethyl or halo, R 2 is hydrogen, chloro or nitro, n is 1 or 2 and pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 20 words
The composition of claim 1 wherein said vaccine is inactivated whole equine herpesvirus 1 and said adjuvant is 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid.
Claim 4
Dependent Claim 18 words
The composition of claim 1 wherein said vaccine is subunit influenza A and said adjuvant is 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid.

References Cited (Backward Citations)

US3704239A Cited
FR2287912A1 Cited
US4158052A Cited
US4214089A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-08-21 1988-02-20 1988-08-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-08-21 1992-02-20 1992-08-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-08-21 1996-02-20 1996-08-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag